Copyright
©2014 Baishideng Publishing Group Inc.
World J Hematol. Nov 6, 2014; 3(4): 128-137
Published online Nov 6, 2014. doi: 10.5315/wjh.v3.i4.128
Published online Nov 6, 2014. doi: 10.5315/wjh.v3.i4.128
Figure 4 Serum granulysin in healthy subjects (A, see GRANULYSIN AS A BIOMARKER in the text) and relationship with natural killer cell activity (B).
Serum granulysin is increased along with the recovery of natural killer (NK) cell activity in infant with combined immunodeficiency after cell therapy.
- Citation: Nagasawa M, Ogawa K, Nagata K, Shimizu N. Granulysin and its clinical significance as a biomarker of immune response and NK cell related neoplasms. World J Hematol 2014; 3(4): 128-137
- URL: https://www.wjgnet.com/2218-6204/full/v3/i4/128.htm
- DOI: https://dx.doi.org/10.5315/wjh.v3.i4.128